Loss-of-function in tumor suppressors Apc, Trp53, Smad4, and oncogenic gain-of-function in Kras (G12D) were sequentially introduced to develop transformed CRC organoids (termed AKPS, depicted in Fig. 2a). This evidence concerns the gene KRAS and neoplasm.